Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.50e-25	114	105	20	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.50e-24	124	105	20	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.23e-23	137	105	20	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 ATG4C USP17L22 USP17L15 USP17L8 USP17L13	4.56e-22	192	105	21	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L7 USP17L21 MBTPS1 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 PHEX USP17L17 USP17L6P USP17L3 ATG4C USP17L22 USP17L15 USP17L8 USP17L13	3.42e-13	654	105	23	GO:0008233
GeneOntologyMolecularFunction	hexosyltransferase activity	GALNT14 GALNT2 RPN2 GCNT1 GALNT16 UGT2B4 UGT2B28 UGT2B11	1.58e-05	211	105	8	GO:0016758
GeneOntologyMolecularFunction	UDP-glycosyltransferase activity	GALNT14 GALNT2 GCNT1 GALNT16 UGT2B4 UGT2B28 UGT2B11	1.64e-05	153	105	7	GO:0008194
GeneOntologyMolecularFunction	glycosyltransferase activity	GALNT14 GALNT2 RPN2 GCNT1 GALNT16 UGT2B4 UGT2B28 UGT2B11	1.41e-04	288	105	8	GO:0016757
GeneOntologyMolecularFunction	polypeptide N-acetylgalactosaminyltransferase activity	GALNT14 GALNT2 GALNT16	1.51e-04	20	105	3	GO:0004653
GeneOntologyMolecularFunction	ligand-gated calcium channel activity	GRIA3 RYR2 MCOLN3	5.71e-04	31	105	3	GO:0099604
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT2B4 UGT2B28 UGT2B11	8.18e-04	35	105	3	GO:0015020
GeneOntologyMolecularFunction	acetylgalactosaminyltransferase activity	GALNT14 GALNT2 GALNT16	8.18e-04	35	105	3	GO:0008376
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.16e-24	125	106	20	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.27e-23	144	106	20	GO:0070646
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 SPOPL PRICKLE1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 KLHL7 USP17L6P USP17L3 ATG4C USP17L22 WDSUB1 MED12 USP17L15 USP17L8 USP17L13	2.30e-11	1074	106	26	GO:0043687
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 SPOPL PRICKLE1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 KLHL7 USP17L6P USP17L3 USP17L22 WDSUB1 MED12 USP17L15 USP17L8 USP17L13	3.69e-11	1009	106	25	GO:0070647
GeneOntologyBiologicalProcess	biphenyl catabolic process	UGT2B4 UGT2B28 UGT2B11	7.25e-06	8	106	3	GO:0070980
GeneOntologyBiologicalProcess	biphenyl metabolic process	UGT2B4 UGT2B28 UGT2B11	1.54e-05	10	106	3	GO:0018879
GeneOntologyBiologicalProcess	xenobiotic glucuronidation	UGT2B4 UGT2B28 UGT2B11	2.81e-05	12	106	3	GO:0052697
GeneOntologyBiologicalProcess	benzene-containing compound metabolic process	UGT2B4 KYAT3 UGT2B28 UGT2B11	3.82e-05	37	106	4	GO:0042537
GeneOntologyBiologicalProcess	estrogen metabolic process	SULT1E1 UGT2B4 UGT2B28 UGT2B11	1.48e-04	52	106	4	GO:0008210
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT2B4 UGT2B28 UGT2B11	1.64e-04	21	106	3	GO:0052695
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L7 USP17L21 MBTPS1 USP17L4 USP17L2 GALNT2 USP17L12 USP17L1 RPN2 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 REEP2 RYR2 USP17L18 USP17L17 UGT2B4 USP17L6P USP17L3 EMC10 UGT2B28 UGT2B11 USP17L22 USP17L15 USP17L8 USP17L13	4.22e-11	1293	107	28	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L7 USP17L21 MBTPS1 USP17L4 USP17L2 GALNT2 USP17L12 USP17L1 RPN2 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 REEP2 RYR2 USP17L18 USP17L17 UGT2B4 USP17L6P USP17L3 EMC10 UGT2B28 UGT2B11 USP17L22 USP17L15 USP17L8 USP17L13	4.71e-11	1299	107	28	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L7 USP17L21 MBTPS1 USP17L4 USP17L2 GALNT2 USP17L12 USP17L1 RPN2 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 REEP2 RYR2 USP17L18 USP17L17 UGT2B4 USP17L6P USP17L3 EMC10 UGT2B28 UGT2B11 USP17L22 USP17L15 USP17L8 USP17L13	7.72e-11	1327	107	28	GO:0042175
GeneOntologyCellularComponent	nuclear envelope	GABRB1 PRICKLE1 BCHE EDNRB RYR2 SULT1E1 UGT2B4 UGT2B28 UGT2B11 DYNC1H1	6.03e-04	560	107	10	GO:0005635
MousePheno	increased thymus weight	USP17L2 RYR2 USP17L15 USP17L13	6.01e-06	24	71	4	MP:0004955
MousePheno	increased trophectoderm apoptosis	USP17L2 USP17L15 USP17L13	6.90e-06	8	71	3	MP:0012119
Domain	HABP4_PAI-RBP1	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	8.51e-31	16	101	14	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	8.51e-31	16	101	14	IPR006861
Domain	UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	7.82e-26	71	101	18	PF00443
Domain	USP_2	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	7.82e-26	71	101	18	PS00973
Domain	USP_3	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.04e-25	72	101	18	PS50235
Domain	USP_dom	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.04e-25	72	101	18	IPR028889
Domain	Peptidase_C19_UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.04e-25	72	101	18	IPR001394
Domain	USP_CS	USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.43e-24	66	101	17	IPR018200
Domain	USP_1	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	4.40e-24	70	101	17	PS00972
Domain	RICIN	GALNT14 GALNT2 GALNT16 PLA2R1	1.49e-05	28	101	4	SM00458
Domain	RICIN_B_LECTIN	GALNT14 GALNT2 GALNT16 PLA2R1	1.49e-05	28	101	4	PS50231
Domain	Ricin_B_lectin	GALNT14 GALNT2 GALNT16 PLA2R1	1.98e-05	30	101	4	IPR000772
Domain	ELM2	TRERF1 MTA2 ZNF541	4.22e-05	13	101	3	PF01448
Domain	ELM2	TRERF1 MTA2 ZNF541	4.22e-05	13	101	3	PS51156
Domain	ELM2_dom	TRERF1 MTA2 ZNF541	4.22e-05	13	101	3	IPR000949
Domain	ELM2	TRERF1 MTA2 ZNF541	4.22e-05	13	101	3	SM01189
Domain	UDPGT	UGT2B4 UGT2B28 UGT2B11	1.90e-04	21	101	3	PF00201
Domain	UDPGT	UGT2B4 UGT2B28 UGT2B11	1.90e-04	21	101	3	PS00375
Domain	UDP_glucos_trans	UGT2B4 UGT2B28 UGT2B11	1.90e-04	21	101	3	IPR002213
Domain	Ricin_B_lectin	GALNT14 GALNT2 GALNT16	3.24e-04	25	101	3	PF00652
Domain	SANT_dom	TRERF1 MTA2 ZNF541	3.65e-04	26	101	3	IPR017884
Domain	PET	TES PRICKLE1	4.28e-04	6	101	2	PF06297
Domain	PET_domain	TES PRICKLE1	4.28e-04	6	101	2	IPR010442
Domain	PET	TES PRICKLE1	4.28e-04	6	101	2	PS51303
Domain	SANT	TRERF1 MTA2 ZNF541	4.56e-04	28	101	3	PS51293
Domain	Glycos_transf_2	GALNT14 GALNT2 GALNT16	5.60e-04	30	101	3	PF00535
Domain	Glyco_trans_2-like	GALNT14 GALNT2 GALNT16	5.60e-04	30	101	3	IPR001173
Domain	Myb_DNA-binding	TRERF1 MTA2 ZNF541	8.86e-04	35	101	3	PF00249
Domain	MYB_LIKE	TRERF1 MTA2 ZNF541	1.13e-03	38	101	3	PS50090
Domain	SANT	TRERF1 MTA2 ZNF541	2.50e-03	50	101	3	SM00717
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DYNC1H1	2.53e-03	14	101	2	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DYNC1H1	2.53e-03	14	101	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH3 DYNC1H1	2.53e-03	14	101	2	IPR013602
Domain	DHC_N2	DNAH3 DYNC1H1	2.53e-03	14	101	2	PF08393
Domain	MT	DNAH3 DYNC1H1	2.53e-03	14	101	2	PF12777
Domain	AAA_8	DNAH3 DYNC1H1	2.53e-03	14	101	2	PF12780
Domain	ATPase_dyneun-rel_AAA	DNAH3 DYNC1H1	2.53e-03	14	101	2	IPR011704
Domain	AAA_5	DNAH3 DYNC1H1	2.53e-03	14	101	2	PF07728
Domain	SANT/Myb	TRERF1 MTA2 ZNF541	2.80e-03	52	101	3	IPR001005
Domain	DHC_fam	DNAH3 DYNC1H1	2.90e-03	15	101	2	IPR026983
Domain	Dynein_heavy_dom	DNAH3 DYNC1H1	2.90e-03	15	101	2	IPR004273
Domain	Dynein_heavy	DNAH3 DYNC1H1	2.90e-03	15	101	2	PF03028
Pathway	REACTOME_RAS_PROCESSING	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.67e-31	45	85	19	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.53e-18	191	85	19	MM15289
Pathway	REACTOME_DEUBIQUITINATION	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 INO80 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.59e-17	262	85	20	MM15286
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.79e-16	221	85	18	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 INO80 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-14	299	85	19	M27574
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.34e-14	318	85	19	MM15278
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L7 GALNT14 USP17L21 MBTPS1 USP17L4 USP17L2 GALNT2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 INO80 GCNT1 GALNT16 USP17L18 EEF2 USP17L17 USP17L6P PLET1 USP17L3 USP17L22 USP17L15 DYNC1H1 USP17L8 USP17L13	4.45e-09	1389	85	28	MM15307
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	GALNT14 USP17L21 MBTPS1 USP17L4 USP17L2 GALNT2 USP17L12 USP17L1 RPN2 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 INO80 GCNT1 GALNT16 USP17L18 EEF2 USP17L17 PLET1 USP17L3 USP17L22 USP17L15 DYNC1H1 USP17L8 USP17L13	1.68e-08	1475	85	28	M19806
Pathway	KEGG_O_GLYCAN_BIOSYNTHESIS	GALNT14 GALNT2 GCNT1 GALNT16	2.99e-05	30	85	4	M6929
Pathway	REACTOME_PARACETAMOL_ADME	SULT1E1 UGT2B4 UGT2B28 UGT2B11	8.62e-05	39	85	4	MM15695
Pathway	REACTOME_ASPIRIN_ADME	BCHE UGT2B4 UGT2B28 UGT2B11	1.39e-04	44	85	4	M45014
Pathway	REACTOME_ASPIRIN_ADME	BCHE UGT2B4 UGT2B28 UGT2B11	1.52e-04	45	85	4	MM15694
Pathway	KEGG_STEROID_HORMONE_BIOSYNTHESIS	SULT1E1 UGT2B4 UGT2B28 UGT2B11	3.32e-04	55	85	4	M14933
Pathway	REACTOME_PREDNISONE_ADME	UGT2B4 UGT2B28 UGT2B11	3.43e-04	23	85	3	MM16639
Pathway	REACTOME_GLUCURONIDATION	UGT2B4 UGT2B28 UGT2B11	3.91e-04	24	85	3	MM14599
Pathway	REACTOME_GLUCURONIDATION	UGT2B4 UGT2B28 UGT2B11	4.42e-04	25	85	3	M17787
Pathway	WP_GLUCURONIDATION	UGT2B4 UGT2B28 UGT2B11	4.42e-04	25	85	3	MM15820
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT2B4 UGT2B28 UGT2B11	4.42e-04	25	85	3	M605
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	GALNT14 GALNT2 GCNT1 GALNT16	4.64e-04	60	85	4	MM15636
Pathway	WP_GLUCURONIDATION	UGT2B4 UGT2B28 UGT2B11	4.98e-04	26	85	3	M39404
Pathway	REACTOME_DRUG_ADME	BCHE SULT1E1 UGT2B4 UGT2B28 UGT2B11	5.06e-04	109	85	5	M45012
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	GALNT14 GALNT2 GCNT1 GALNT16	5.26e-04	62	85	4	M546
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT2B4 UGT2B28 UGT2B11	6.22e-04	28	85	3	M19580
Pathway	REACTOME_DRUG_ADME	BCHE SULT1E1 UGT2B4 UGT2B28 UGT2B11	7.54e-04	119	85	5	MM15692
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.20e-47	21	107	19	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.20e-47	21	107	19	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.20e-47	21	107	19	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.20e-47	21	107	19	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.20e-47	21	107	19	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.20e-47	21	107	19	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.27e-46	22	107	19	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.45e-44	24	107	19	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.02e-44	25	107	19	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.23e-43	26	107	19	35816173
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.85e-43	33	107	20	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.17e-42	34	107	20	20403174
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.17e-42	34	107	20	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.17e-42	34	107	20	20388806
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.17e-42	34	107	20	14699124
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.17e-42	34	107	20	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.17e-42	34	107	20	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.17e-42	34	107	20	20368735
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.17e-42	34	107	20	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.17e-42	34	107	20	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.17e-42	34	107	20	11941478
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.17e-42	34	107	20	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.17e-42	34	107	20	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.73e-42	35	107	20	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.73e-42	35	107	20	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.14e-42	36	107	20	20147298
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.74e-42	29	107	19	32527007
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.33e-41	37	107	20	20228808
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	9.73e-36	50	107	19	31806660
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	2.75e-19	10	107	8	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	3.01e-18	12	107	8	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	1.82e-17	14	107	8	11793228
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 GRIA3 BCHE USP17L10 USP17L19 USP17L18 PLA2R1 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.24e-16	674	107	22	37196079
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	4.52e-16	19	107	8	28067227
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	1.64e-10	81	107	8	12838346
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L7 USP17L4 USP17L1 DOCK5 USP17L3 USP17L8	8.13e-09	48	107	6	16421571
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	9.03e-08	119	107	7	28625976
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L2 USP17L15 USP17L13	1.13e-07	4	107	3	22984479
Pubmed	Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.	UGT2B4 UGT2B28 UGT2B11	9.82e-07	7	107	3	26074487
Pubmed	Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.	UGT2B4 UGT2B28 UGT2B11	1.57e-06	8	107	3	32093886
Pubmed	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.	FMO6P SULT1E1 UGT2B4 UGT2B28 UGT2B11	1.93e-06	66	107	5	19898482
Pubmed	TRIM27 cooperates with STK38L to inhibit ULK1-mediated autophagy and promote tumorigenesis.	RPN2 EEF2 CSNK1A1L CSNK1A1 STK38L	2.08e-06	67	107	5	35670107
Pubmed	Casein kinase 1α is required to maintain murine hypothalamic pro-opiomelanocortin expression.	LEPR CSNK1A1L CSHL1 CSNK1A1	2.50e-06	31	107	4	37168577
Pubmed	Systems biology approach identifies the kinase Csnk1a1 as a regulator of the DNA damage response in embryonic stem cells.	CSNK1A1L CSNK1A1	9.38e-06	2	107	2	23354688
Pubmed	Whole exome sequencing identifies hemizygous deletions in the UGT2B28 and USP17L2 genes in a three‑generation family with endometriosis.	USP17L2 UGT2B28	9.38e-06	2	107	2	30628680
Pubmed	Tissue-specific distribution of mouse casein kinase I alpha mRNA.	CSNK1A1L CSNK1A1	9.38e-06	2	107	2	9522121
Pubmed	Gender-specific expression and mechanism of regulation of estrogen sulfotransferase in adipose tissues of the mouse.	LEPR SULT1E1	9.38e-06	2	107	2	18669602
Pubmed	Drosophila glucome screening identifies Ck1alpha as a regulator of mammalian glucose metabolism.	CSNK1A1L CSNK1A1	9.38e-06	2	107	2	25994086
Pubmed	CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling.	CSNK1A1L CSNK1A1	9.38e-06	2	107	2	37723657
Pubmed	Casein Kinase 1α Regulates Testosterone Synthesis and Testis Development in Adult Mice.	CSNK1A1L CSNK1A1	9.38e-06	2	107	2	36929849
Pubmed	GALNT2/14 overexpression correlate with prognosis and methylation: potential therapeutic targets for lung adenocarcinoma.	GALNT14 GALNT2	9.38e-06	2	107	2	33964375
Pubmed	Class III β-Tubulin Expression Is of Value in Selecting nab -Paclitaxel and Gemcitabine as First-Line Therapy in Unresectable Pancreatic Cancer.	CSNK1A1L CSNK1A1	9.38e-06	2	107	2	35695793
Pubmed	Quantitative analysis of UGT2B28 mRNA expression by real-time RT-PCR and application to human tissue distribution study.	UGT2B28 UGT2B11	9.38e-06	2	107	2	21679149
Pubmed	Exploring the role of casein kinase 1α splice variants across cancer cell lines.	CSNK1A1L CSNK1A1	9.38e-06	2	107	2	38852281
Pubmed	PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis.	LEPR PPP1R3C	9.38e-06	2	107	2	31181215
Pubmed	Casein kinase 1 alpha regulates chromosome congression and separation during mouse oocyte meiotic maturation and early embryo development.	CSNK1A1L CSNK1A1	9.38e-06	2	107	2	23690993
Pubmed	Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma.	CSNK1A1L CSNK1A1	9.38e-06	2	107	2	34216174
Pubmed	Casein Kinase 1α as a Novel Factor Affects Thyrotropin Synthesis via PKC/ERK/CREB Signaling.	CSNK1A1L CSNK1A1	9.38e-06	2	107	2	37108197
Pubmed	Dedicator of Cytokinesis 5 Regulates Keratinocyte Function and Promotes Diabetic Wound Healing.	LEPR DOCK5	9.38e-06	2	107	2	33627322
Pubmed	Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice.	CSNK1A1L CSNK1A1	9.38e-06	2	107	2	36542875
Pubmed	Embryonic expression of three mouse genes with homology to the Drosophila melanogaster prickle gene.	TES PRICKLE1	2.81e-05	3	107	2	14516664
Pubmed	CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation.	CSNK1A1L CSNK1A1	2.81e-05	3	107	2	28878021
Pubmed	The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransferases correlates with gender-dependent susceptibility to hyperglycemia.	LEPR SULT1E1	2.81e-05	3	107	2	2912706
Pubmed	Type I Interferons Control Proliferation and Function of the Intestinal Epithelium.	CSNK1A1L CSNK1A1	2.81e-05	3	107	2	26811327
Pubmed	Obesity-induced diabetes (diabesity) in C57BL/KsJ mice produces aberrant trans-regulation of sex steroid sulfotransferase genes.	LEPR SULT1E1	2.81e-05	3	107	2	8182132
Pubmed	Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling.	CSNK1A1L CSNK1A1	2.81e-05	3	107	2	19805514
Pubmed	The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn.	GRIA3 LYN	2.81e-05	3	107	2	9892356
Pubmed	cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily.	UGT2B4 UGT2B11	2.81e-05	3	107	2	8333863
Pubmed	Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia.	CSNK1A1L CSNK1A1	2.81e-05	3	107	2	24616378
Pubmed	Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.	CSNK1A1L CSNK1A1	2.81e-05	3	107	2	25242043
Pubmed	Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors.	CSNK1A1L CSNK1A1	2.81e-05	3	107	2	28655862
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	ROCK2 GALNT2 TRIO RPN2 SEPTIN9 THUMPD3 SPECC1 EEF2 EMC10 PLCB4 EIF3A DIAPH3 LYN DYNC1H1	4.50e-05	1297	107	14	33545068
Pubmed	Loss of the disease-associated glycosyltransferase Galnt3 alters Muc10 glycosylation and the composition of the oral microbiome.	GALNT14 GALNT2 GALNT16	5.47e-05	24	107	3	31882545
Pubmed	Galnt11 regulates kidney function by glycosylating the endocytosis receptor megalin to modulate ligand binding.	GALNT14 GALNT2 GALNT16	5.47e-05	24	107	3	31740596
Pubmed	Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation.	CSNK1A1L CSNK1A1	5.60e-05	4	107	2	38147624
Pubmed	Mammary ductal growth is impaired in mice lacking leptin-dependent signal transducer and activator of transcription 3 signaling.	LEPR EDNRB	5.60e-05	4	107	2	20501669
Pubmed	The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic.	CSNK1A1L CSNK1A1	5.60e-05	4	107	2	32728212
Pubmed	FAM83D directs protein kinase CK1α to the mitotic spindle for proper spindle positioning.	CSNK1A1L CSNK1A1	5.60e-05	4	107	2	31338967
Pubmed	Cx43 phosphorylation sites regulate pancreatic cancer metastasis.	CSNK1A1L CSNK1A1	5.60e-05	4	107	2	33603164
Pubmed	DOCK5 regulates energy balance and hepatic insulin sensitivity by targeting mTORC1 signaling.	LEPR DOCK5	5.60e-05	4	107	2	31885214
Pubmed	Regulation of p53-MDMX interaction by casein kinase 1 alpha.	CSNK1A1L CSNK1A1	5.60e-05	4	107	2	16024788
Pubmed	A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma.	CSNK1A1L CSNK1A1	5.60e-05	4	107	2	30487124
Pubmed	Altered contribution of RhoA/Rho kinase signaling in contractile activity of myometrium in leptin receptor-deficient mice.	ROCK2 LEPR	5.60e-05	4	107	2	21558549
Pubmed	The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs.	MTA2 GALNT2 RPN2 SEPTIN9 EEF2 EIF3A STK38L	6.21e-05	320	107	7	28685749
Pubmed	LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.	SEPTIN9 IDH1 EEF2 EIF3A DYNC1H1	8.04e-05	142	107	5	30809309
Pubmed	Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice.	CSNK1A1L CSNK1A1	9.32e-05	5	107	2	30064974
Pubmed	A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism.	CSNK1A1L CSNK1A1	9.32e-05	5	107	2	23890787
Pubmed	CK1α deficiency impairs mouse uterine adenogenesis by inducing epithelial cell apoptosis through GSK3β pathway and inhibiting Foxa2 expression through p53 pathway†.	CSNK1A1L CSNK1A1	9.32e-05	5	107	2	37944068
Pubmed	Glutaredoxin 1 protects lens epithelial cells from epithelial-mesenchymal transition by preventing casein kinase 1α S-glutathionylation during posterior capsular opacification.	CSNK1A1L CSNK1A1	9.32e-05	5	107	2	36989576
Pubmed	CKIα ablation highlights a critical role for p53 in invasiveness control.	CSNK1A1L CSNK1A1	9.32e-05	5	107	2	21331045
Pubmed	Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome.	CSNK1A1L CSNK1A1	9.32e-05	5	107	2	30651631
Pubmed	A study of the nature of embryonic lethality in LIS1-/- mice.	NDE1 DYNC1H1	9.32e-05	5	107	2	12950100
Pubmed	Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice.	ROCK2 LEPR	9.32e-05	5	107	2	19666843
Pubmed	Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer.	CSNK1A1L CSNK1A1	9.32e-05	5	107	2	25628462
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	USP17L7 DNAH3 USP17L12 SEPTIN9 PRDM2 DOCK5 USP17L3 EIF3A LYN DYNC1H1	9.41e-05	736	107	10	29676528
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	MTA2 RPN2 SEPTIN9 SPECC1 EEF2 EIF3A DDX21 DYNC1H1	1.18e-04	477	107	8	31300519
Pubmed	Casein kinase I and casein kinase II differentially regulate axin function in Wnt and JNK pathways.	CSNK1A1L CSNK1A1	1.40e-04	6	107	2	11884395
Pubmed	Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets.	RPN2 INO80	1.40e-04	6	107	2	28598414
Pubmed	Physiological role for casein kinase 1 in glutamatergic synaptic transmission.	CSNK1A1L CSNK1A1	1.40e-04	6	107	2	16014721
Pubmed	MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism.	CSNK1A1L CSNK1A1	1.40e-04	6	107	2	33667384
Cytoband	4p16.1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	6.33e-23	79	107	14	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	2.07e-16	222	107	14	chr4p16
Cytoband	8p23.1	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.77e-06	154	107	6	8p23.1
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.93e-05	234	107	6	chr8p23
Cytoband	Ensembl 112 genes in cytogenetic band chr4q13	SULT1E1 UGT2B4 UGT2B28 UGT2B11	5.17e-04	157	107	4	chr4q13
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	TRERF1 MTA2 MSANTD2 ZNF541	3.24e-05	53	62	4	532
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNT14 GALNT2 GALNT16	4.20e-05	20	62	3	433
GeneFamily	UDP glucuronosyltransferases	UGT2B4 UGT2B28 UGT2B11	1.77e-04	32	62	3	363
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L7 USP17L21 USP17L4 TES USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 PHEX USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.44e-29	112	106	21	MM1095
Coexpression	MADAN_DPPA4_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.71e-28	86	106	19	MM1312
Coexpression	GERY_CEBP_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 SLFN12L USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.89e-24	160	106	20	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 IDH1 MORC4 USP17L18 PLA2R1 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 SPRYD4 USP17L8 USP17L13	1.19e-15	647	106	23	MM981
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L7 ROCK2 USP17L21 USP17L4 TES USP17L2 ING3 USP17L12 USP17L1 USP17L20 USP17L11 THUMPD3 USP17L5 USP17L10 USP17L19 IDH1 USP17L18 SNX30 SLFN12L USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.03e-13	1072	106	26	MM1031
Coexpression	BRUINS_UVC_RESPONSE_LATE	GABRB1 USP17L7 USP17L21 USP17L4 USP17L2 GALNT2 USP17L12 USP17L1 USP17L20 USP17L11 SEPTIN9 USP17L5 USP17L10 USP17L19 USP17L18 PTPRG USP17L17 USP17L6P PLET1 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.87e-11	1198	106	24	MM1062
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 IDH1 MORC4 USP17L18 PLA2R1 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 SPRYD4 USP17L8 USP17L13	5.70e-10	1226	106	23	MM979
Coexpression	PILON_KLF1_TARGETS_UP	TRIO EPB41L5 EDNRB CSNK1A1L SBNO1 CSNK1A1 UGT2B4 TTC39A UGT2B28 UGT2B11	6.99e-05	541	106	10	MM1061
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	GALNT2 TRIO SPOPL WDFY4 PRDM2 LYN DDX21	8.68e-08	163	100	7	6bed27d2f67a430a847da5eb47878d14b4949c45
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRIO SPOPL WDFY4 PRDM2 LYN DDX21	2.62e-06	173	100	6	d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	BCHE RYR2 SULT1E1 PPP1R3C PHEX PLA2R1	4.63e-06	191	100	6	fa380a8752de158974b2ae5e741573439719cc0d
ToppCell	VE-pDC-\|VE / Condition, Cell_class and T cell subcluster	PPM1J WDFY4 PHEX TTC39A PLCB4 LYN	4.92e-06	193	100	6	583724de588fcde3aeda056138c522dc0225a387
ToppCell	VE-pDC\|VE / Condition, Cell_class and T cell subcluster	PPM1J WDFY4 PHEX TTC39A PLCB4 LYN	4.92e-06	193	100	6	bb759dc9ef0ec41d655002f59021d62d62d44289
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TRERF1 PPP1R3C DOCK5 SLFN12L PTPRG UNC13C	5.06e-06	194	100	6	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TRERF1 PPP1R3C DOCK5 SLFN12L PTPRG UNC13C	5.22e-06	195	100	6	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	COVID-19-Lymphoid-pDC\|Lymphoid / Condition, Lineage and Cell class	PPM1J WDFY4 PHEX TTC39A PLCB4 LYN	5.22e-06	195	100	6	4a7c080230ce6a79335ecbeadecb0177b2c13625
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BCHE SPECC1 SULT1E1 UNC13C PLCB4	3.55e-05	165	100	5	369d77a80d6401e85ea3121ab5a252f67d5f157e
ToppCell	356C-Fibroblasts-Fibroblast-D\|356C / Donor, Lineage, Cell class and subclass (all cells)	PRICKLE1 BCHE LEPR RYR2 PLA2R1	3.65e-05	166	100	5	7286a37b2827f3747469ffd0d76cbe81116db7ee
ToppCell	356C-Fibroblasts-Fibroblast-D-\|356C / Donor, Lineage, Cell class and subclass (all cells)	PRICKLE1 BCHE LEPR RYR2 PLA2R1	3.65e-05	166	100	5	7c2eee0a4f45795a956acf936b85bdb35f1b1624
ToppCell	mild_COVID-19-pDC\|mild_COVID-19 / disease group, cell group and cell class (v2)	PPM1J WDFY4 PHEX TTC39A PLCB4	4.70e-05	175	100	5	b87f279a7519710146c49d6acccb0adedc195965
ToppCell	PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	WDFY4 PLET1 TTC39A DIAPH3 SPRYD4	5.23e-05	179	100	5	9dea57494d59abd6e8abf34e31faf53462ea0fa0
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BCHE RYR2 SULT1E1 PHEX MCOLN3	5.37e-05	180	100	5	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BCHE SULT1E1 PPP1R3C PHEX MCOLN3	5.37e-05	180	100	5	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BCHE SULT1E1 PPP1R3C PHEX MCOLN3	5.51e-05	181	100	5	9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RYR2 SULT1E1 PHEX UGT2B4 MCOLN3	5.51e-05	181	100	5	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SEPTIN9 IDH1 PLET1 EIF3A MCOLN3	5.96e-05	184	100	5	fe9ea4d0e0be820e95eaf9bb42a5560d0e177574
ToppCell	systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PPM1J WDFY4 PHEX TTC39A PLCB4	6.11e-05	185	100	5	cc5152d3055375172bdf84f442b233c8fbd422b3
ToppCell	Healthy_donor-pDC\|Healthy_donor / disease group, cell group and cell class (v2)	PPM1J WDFY4 PHEX TTC39A PLCB4	6.11e-05	185	100	5	7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8
ToppCell	droplet-Lung-LUNG-1m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEPTIN9 IDH1 WDFY4 PLET1 LYN	6.11e-05	185	100	5	53a5218c1e6eb12daccde3d6e02f337e2586d74c
ToppCell	Myeloid-B_(Activated_Macrophage)\|World / shred on cell class and cell subclass (v4)	SEPTIN9 IDH1 PLET1 EIF3A MCOLN3	6.27e-05	186	100	5	33d731a7883d75e4e7db83b641cdb1e9a39938bf
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SEPTIN9 IDH1 PLET1 EIF3A MCOLN3	6.27e-05	186	100	5	7950e03ea080238c168b9d807e217f459acdfb28
ToppCell	Healthy_donor-pDC\|World / disease group, cell group and cell class (v2)	PPM1J WDFY4 PHEX TTC39A PLCB4	6.43e-05	187	100	5	aa2cc54487d3c5045ac0c93560944c5a55878e27
ToppCell	COVID-19_Severe-pDC\|World / disease group, cell group and cell class	GALNT2 PPM1J WDFY4 PHEX TTC39A	6.59e-05	188	100	5	4c8e328b8206120708b05ea3c5865a0200dc5c4e
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	ROCK2 SPECC1 UNC13C PLCB4 STK38L	6.76e-05	189	100	5	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	Control-Myeloid-pDC\|Control / Disease group, lineage and cell class	PPM1J WDFY4 PHEX TTC39A PLCB4	6.76e-05	189	100	5	46770b99da42f11f10cfc67cea8562342d60b867
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PPM1J WDFY4 PHEX TTC39A PLCB4	6.93e-05	190	100	5	adffa93635da10251f28b2089fd96b189775c8b4
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPM1J WDFY4 PHEX TTC39A PLCB4	6.93e-05	190	100	5	9a91bf1ea105029e6412d0d9060bca325299ce26
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PPM1J WDFY4 PHEX TTC39A PLCB4	6.93e-05	190	100	5	39c8ddc2639bf3e986dae11fbae61a735614b604
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPM1J WDFY4 PHEX TTC39A PLCB4	6.93e-05	190	100	5	2c1c079fd411c03bc3f383aa927eea9446716960
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPM1J WDFY4 PHEX TTC39A PLCB4	6.93e-05	190	100	5	a95aea3aa707fc4574810706341a5f32b3d00209
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PPM1J WDFY4 PHEX TTC39A PLCB4	6.93e-05	190	100	5	18dfa84c62dcf081ce9958a71e76a394ec0968e4
ToppCell	(011)_pDC\|World / immune cells in Peripheral Blood (logTPM normalization)	PPM1J WDFY4 PHEX TTC39A PLCB4	7.11e-05	191	100	5	d82ac4f6d9863734e09bf3cb71c1354a49b66b4f
ToppCell	(01)_Dendritic_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	PPM1J SPECC1 WDFY4 PHEX TTC39A	7.11e-05	191	100	5	1f4c8078e1a6cd14937c714330af608caced2acf
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ROCK2 CACHD1 EDNRB PLA2R1 PLCB4	7.11e-05	191	100	5	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TRERF1 GRIA3 BCHE SLFN12L UNC13C	7.28e-05	192	100	5	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRIO WDFY4 PRDM2 LYN DDX21	7.46e-05	193	100	5	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLET1 TTC39A PLCB4 STK38L SPTY2D1	7.46e-05	193	100	5	6a9bce5064938b5b84ad57b4fd4a7841afe100c8
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RYR2 PHEX PTPRG UGT2B4 MCOLN3	7.46e-05	193	100	5	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	RYR2 PPP1R3C PHEX PTPRG UNC13C	7.46e-05	193	100	5	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RYR2 PPP1R3C PHEX PTPRG UNC13C	7.65e-05	194	100	5	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 PRICKLE1 EDNRB PLA2R1 MCOLN3	7.65e-05	194	100	5	240d122dcb9dd1ab2867503ad85869853adcacae
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RYR2 SULT1E1 PPP1R3C UGT2B4 UNC13C	7.65e-05	194	100	5	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 PRICKLE1 EDNRB PLA2R1 MCOLN3	7.65e-05	194	100	5	ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	WASHC4 GALNT2 WDFY4 PRDM2 LYN	7.65e-05	194	100	5	d852aebf7a763b9a776c4570711f0c759f591910
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|GI_small-bowel / Manually curated celltypes from each tissue	SPECC1 DOCK5 EEF2 LYN CD96	8.03e-05	196	100	5	5755ca4abcae3717894bbf7cbd49bca0a3a03067
ToppCell	severe-pDC\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	GABRB1 PPM1J WDFY4 PHEX TTC39A	8.42e-05	198	100	5	22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ROCK2 ENTPD4 EDNRB PLCB4 DYNC1H1	8.83e-05	200	100	5	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ROCK2 TRIO LEPR PTPRG PLCB4	8.83e-05	200	100	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ROCK2 ENTPD4 EDNRB PLCB4 DYNC1H1	8.83e-05	200	100	5	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Control_saline-Endothelial-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	ROCK2 ENTPD4 EDNRB PTPRG PLCB4	8.83e-05	200	100	5	e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCell	Control_saline-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	ROCK2 ENTPD4 EDNRB PTPRG PLCB4	8.83e-05	200	100	5	3372c488a39fe812fa94e4f0564594186fea3db5
Drug	UDP-N-acetylglucosamine	GALNT14 GALNT2 GCNT1 GALNT16 ENTPD4 UGT2B4 UGT2B28 UGT2B11	1.71e-06	203	92	8	CID000001167
Drug	UDP - Na	GALNT14 GALNT2 GCNT1 GALNT16 ENTPD4 UGT2B4 UGT2B28 UGT2B11	5.05e-06	235	92	8	CID000001158
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.28e-38	46	103	20	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.02e-33	69	103	20	DOID:1682 (implicated_via_orthology)
Disease	serum amyloid A-1 protein measurement	BCHE LEPR SPTY2D1	3.24e-05	18	103	3	EFO_0008282
Disease	phosphatidylcholine 36:4 measurement	UGT2B4 UGT2B28 UGT2B11	3.24e-05	18	103	3	EFO_0010382
Disease	syndromic X-linked intellectual disability Najm type (implicated_via_orthology)	CSNK1A1L CSNK1A1	2.51e-04	7	103	2	DOID:0060807 (implicated_via_orthology)
Disease	epilepsy (implicated_via_orthology)	TRIO NDE1 PRICKLE1 UNC13C DYNC1H1	2.74e-04	163	103	5	DOID:1826 (implicated_via_orthology)
Disease	plasma clozapine-to-N-desmethylclozapine ratio measurement	UGT2B4 UGT2B11	4.28e-04	9	103	2	EFO_0600040
Disease	Mammary Carcinoma, Human	TRERF1 BCHE GALNT16 LEPR EDNRB EEF2 ALKBH8 MED12	5.16e-04	525	103	8	C4704874
Disease	Mammary Neoplasms, Human	TRERF1 BCHE GALNT16 LEPR EDNRB EEF2 ALKBH8 MED12	5.16e-04	525	103	8	C1257931
Disease	Mammary Neoplasms	TRERF1 BCHE GALNT16 LEPR EDNRB EEF2 ALKBH8 MED12	5.29e-04	527	103	8	C1458155
Disease	Breast Carcinoma	TRERF1 BCHE GALNT16 LEPR EDNRB EEF2 ALKBH8 MED12	6.06e-04	538	103	8	C0678222
Disease	X-19141 measurement	UGT2B4 UGT2B11	9.18e-04	13	103	2	EFO_0800799
Disease	Proteinuria	FAM151B UNC13C	1.23e-03	15	103	2	HP_0000093
Disease	disease progression measurement	UGT2B4 EIF3A UGT2B11	1.28e-03	61	103	3	EFO_0008336
Disease	bacteriemia	PTPRG UGT2B4	1.59e-03	17	103	2	EFO_0003033
Disease	Tachycardia	BCHE RYR2	1.78e-03	18	103	2	C0039231
Disease	Tachyarrhythmia	BCHE RYR2	1.78e-03	18	103	2	C0080203
Disease	X-24947 measurement	UGT2B4 UGT2B11	2.66e-03	22	103	2	EFO_0800910
Disease	Giant Cell Glioblastoma	TES BCHE IDH1	3.21e-03	84	103	3	C0334588

Protein segments in the cluster

Peptide	Gene	Start	Entry
YMISYSWTKNEDEKE	PTPRG	381	P23470
YMMDWKNQFNDYTSK	BCHE	581	P06276
IYVWAMEQEYNKQKS	ALKBH8	501	Q96BT7
VDYIGMENFWKRYNK	CCDC65	396	Q8IXS2
TGKEAYNVSYAWKMV	CACHD1	581	Q5VU97
WGMEAYITKEQKYSF	CSHL1	61	Q14406
DWQSVMQYVAQIYKY	SPECC1	1051	Q5M775
QKTAFMQFYKTAKDW	EDNRB	261	P24530
VYVLKSNSGEKYWMF	AASDH	836	Q4L235
EAYDVYNMVWSTVKE	DIAPH3	416	Q9NSV4
NNMKYSWVLKTKTYF	ATG4C	21	Q96DT6
KMNCKSFRWYLENVY	GALNT16	406	Q8N428
TRVQKMNWKNVYYKF	MSANTD2	361	Q6P1R3
MNWKNVYYKFLEITI	MSANTD2	366	Q6P1R3
FYYMWKTTDRYIQQK	MTA2	306	O94776
QDVKYFQRVKWQYMV	INO80	636	Q9ULG1
WYNTSVMRKVKFYDE	MBTPS1	726	Q14703
FATFAKMQQKSYLVW	MCOLN3	461	Q8TDD5
EVWMDEYKNFYYAAV	GALNT2	386	Q10471
IAVYEKMWSYMKSAE	GRIA3	696	P42263
EWREEQMASIKKDYY	ING3	56	Q9NXR8
VNEGYSWTMVKEMEY	FAM151B	176	Q6UXP7
LSGKEVQWKMYEVYD	LEPR	576	P48357
VQWKMYEVYDAKSKS	LEPR	581	P48357
TKYLWEQLQKMAEYY	MED12	191	Q93074
DYTLTMYFQQSWKDK	GABRB1	81	P18505
YVQKMNTWFKHENYG	FMO6P	256	O60774
RMDCYNVVKDSWYSK	KLHL7	351	Q8IXQ5
QYDYTFDWTMLKQKA	CSNK1A1L	291	Q8N752
KRTAEVWMDEYKQYY	GALNT14	356	Q96FL9
SLASKKYQSDMYWAQ	PRICKLE1	461	Q96MT3
FTCNWKMKYVTFEDE	EFCAB5	761	A4FU69
AETNYLNKAKWLEMY	EPB41L5	216	Q9HCM4
YDKQYKSQFEAQKIW	IDH1	231	O75874
ALDNMFSSKYTWVKY	GKN2	106	Q86XP6
YQEIISYFDKGKMWE	DOCK5	1301	Q9H7D0
NKLYWAVFSEYVKTM	GNPAT	216	O15228
MKLDWVNVTFSFVKY	DNAH3	1011	Q8TD57
LMANYYNKVSTVFWK	EIF3A	271	Q14152
VWMGYYNNSTKVAVK	LYN	261	P07948
EECRYKLYQEMFAWK	DYNC1H1	976	Q14204
WAFTLKQFAEMYVAK	EEF2	221	P13639
PQEQKSFFAKYWMYI	EMC10	216	Q5UCC4
WVFNVAKKYMKSTYE	DDX21	381	Q9NR30
KDLYAMSANWKYLIN	GCNT1	201	Q02742
SQSYVKMYNKAVKLW	SBNO1	551	A3KN83
GSAQYKKWYYELMVD	RYR2	666	Q92736
DMKNNEPYDYKFVKW	KYAT3	386	Q6YP21
RSQVKNNVYMWEVYY	PRDM2	66	Q13029
KNYVEVTRKWYAEAM	MTX1	266	Q13505
VWDLNMYKSEYFIKQ	TAS2R10	161	Q9NYW0
VDMIYFWKNEKLYCG	TES	276	Q9UGI8
DGAWVVKMFYSFQDK	STK38L	146	Q9Y2H1
TVEDEQAWMASYKYV	PLCB4	541	Q15147
DSWKNYTDVDCVYMK	PPP1R3C	191	Q9UQK1
YAQRKWYTMLANEKA	SPRYD4	126	Q8WW59
KENVKDYYQKWMEEQ	SNRPC	31	P09234
QYDYTFDWTMLKQKA	CSNK1A1	291	P48729
LKYQCFKSAWMFEVF	ENTPD4	486	Q9Y227
YWSKKHMGYRQAEFQ	MORC4	826	Q8TE76
YRDQNMTGWAYKKIE	PPM1J	341	Q5JR12
WQPIMKFINDQYEKY	SEPTIN9	376	Q9UHD8
YALRYMESSWKEQQK	SPTY2D1	636	Q68D10
FCVERGNMKWNYKYD	SIGLEC12	121	Q96PQ1
YKIINANMTWYAAIK	PLA2R1	1126	Q13018
KSWNKKFYDYEANMP	NKAPD1	91	Q6ZUT1
YYVKDQYMTVLEAQW	PLET1	101	Q6UQ28
FSYVKAQEGQWYKMD	USP17L3	336	A6NCW0
FSYVKAQEGQWYKMD	USP17L4	336	A6NCW7
NVKEYVKWMMYWIVF	REEP2	31	Q9BRK0
MEKKWKYCAVYYIIQ	CD96	1	P40200
DYMNLHFKVKWFYNE	UNC13C	1656	Q8NB66
YYWTTAQTMKDLEKA	SLFN12L	541	Q6IEE8
GILMYKDFVKYWDNV	SULT1E1	16	P49888
KNIQYYEKCLMAWES	SNX30	411	Q5VWJ9
VKNMIYVLYFEFWFQ	UGT2B4	211	P06133
YVYWTQLNMFQTLKY	RPN2	591	P04844
SWCYTQVKVVKFSYM	SPOPL	21	Q6IQ16
FSYVKAQEGQWYKMD	USP17L18	336	D6R9N7
FSYVKAQEGQWYKMD	USP17L5	336	A8MUK1
KWQKRDISNFEYLMY	WDFY4	2541	Q6ZS81
FSYVKAQEGQWYKMD	USP17L21	336	D6R901
FSYVKAQEGQWYKMD	USP17L13	336	C9JLJ4
KCMINQYSNYYWKKA	PHEX	616	P78562
MSNYDVPEKWAKFYT	ROCK2	181	O75116
FSYVKAQEGQWYKMD	USP17L19	336	D6RCP7
FSYVKAQEVQWYKMD	USP17L1	336	Q7RTZ2
VKNMIYVLYFDFWFQ	UGT2B11	211	O75310
YVLYFDFWFQMSDMK	UGT2B11	216	O75310
YFKWKADMTNFDVEV	THUMPD3	256	Q9BV44
FSYVKAQEGQWYKMD	USP17L12	336	C9JPN9
FSYVKAQEGQWYKMD	USP17L24	336	Q0WX57
DVQSYYVFVSSWMMK	WASHC4	401	Q2M389
FSYVKAQEGQWYKMD	USP17L7	336	P0C7H9
FSYVKAQEGQWYKMD	USP17L8	336	P0C7I0
FSYVKAQEGQWYKMD	USP17L6P	336	Q6QN14
GYSYEKEAMENWISK	WDSUB1	426	Q8N9V3
VKNMIYVLYFDFWFQ	UGT2B28	211	Q9BY64
FSYVKAQEGQWYKMD	USP17L22	336	D6RA61
FSYVKAQEGQWYKMD	USP17L15	336	C9J2P7
FSYVKAQEGQWYKMD	USP17L17	336	D6RBQ6
KENCWSKATYIYMKA	TTC39A	381	Q5SRH9
FSYVKAQEGQWYKMD	USP17L2	336	Q6R6M4
WADKFQMYVTYCKNK	TRIO	1376	O75962
FSYVKAQEGQWYKMD	USP17L20	336	D6RJB6
SSYVKAQEGQWYKMD	USP17L10	336	C9JJH3
VAQCVEYYYIWKKMI	ZNF541	1196	Q9H0D2
FSYVKAQEGQWYKMD	USP17L11	336	C9JVI0
VAQCVEYYYTWKKIM	TRERF1	921	Q96PN7
NYWKDLAMTYKQRAE	NDE1	16	Q9NXR1